A pilot study of the association of markers of cholesterol synthesis with disturbed sleep in smith-lemli-opitz syndrome

Kurt Freeman, Erin Olufs, Megan Tudor, Jean-Baptiste Roullet, Robert D. Steiner

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. Method: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. Results: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. Conclusion: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.

Original languageEnglish (US)
Pages (from-to)424-430
Number of pages7
JournalJournal of Developmental and Behavioral Pediatrics
Volume37
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Smith-Lemli-Opitz Syndrome
Sleep
Cholesterol
Biomarkers
Phenotype
Mevalonic Acid
Behavioral Symptoms
Inborn Genetic Diseases
Sterols
Habits

Keywords

  • Phenotype
  • Sleep
  • Smith-Lemli-Opitz syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

A pilot study of the association of markers of cholesterol synthesis with disturbed sleep in smith-lemli-opitz syndrome. / Freeman, Kurt; Olufs, Erin; Tudor, Megan; Roullet, Jean-Baptiste; Steiner, Robert D.

In: Journal of Developmental and Behavioral Pediatrics, Vol. 37, No. 5, 2016, p. 424-430.

Research output: Contribution to journalArticle

@article{4aad5ac95a2546499498614986b4affa,
title = "A pilot study of the association of markers of cholesterol synthesis with disturbed sleep in smith-lemli-opitz syndrome",
abstract = "Objective: Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. Method: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. Results: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. Conclusion: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.",
keywords = "Phenotype, Sleep, Smith-Lemli-Opitz syndrome",
author = "Kurt Freeman and Erin Olufs and Megan Tudor and Jean-Baptiste Roullet and Steiner, {Robert D.}",
year = "2016",
doi = "10.1097/DBP.0000000000000317",
language = "English (US)",
volume = "37",
pages = "424--430",
journal = "Journal of Developmental and Behavioral Pediatrics",
issn = "0196-206X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - A pilot study of the association of markers of cholesterol synthesis with disturbed sleep in smith-lemli-opitz syndrome

AU - Freeman, Kurt

AU - Olufs, Erin

AU - Tudor, Megan

AU - Roullet, Jean-Baptiste

AU - Steiner, Robert D.

PY - 2016

Y1 - 2016

N2 - Objective: Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. Method: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. Results: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. Conclusion: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.

AB - Objective: Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by cholesterol synthesis impairment. A host of physical, developmental, and behavioral presentations are associated with SLOS, many of which have been related with disorder severity. Sleep disturbance is commonly reported in SLOS. This study is the first to examine the association between sleep disturbance and biomarkers of cholesterol synthesis defect. Method: Twenty youth with SLOS participated. Biomarkers of cholesterol synthesis were obtained, including plasma sterols (i.e., 7-dehydrocholesterol, 8-dehydrocholesterol, and cholesterol), mevalonic acid, and 24-S hydroxycholsterol. A ratio of plasma cholesterol precursors to cholesterol levels was used as a measure of biochemical severity. Parents reported their children's sleep problems using the Children's Sleep Habits Questionnaire. Results: Most markers of cholesterol synthesis disruption were associated with overall sleep disturbance. Biochemical severity of SLOS was also associated with specific sleep problems (e.g., decreased sleep duration and increased sleep onset delay) and was identified as a significant predictor of these factors. Conclusion: This study is the first to demonstrate associative relationships between cholesterol levels and sleep disturbance in youth with SLOS. These results add to the current understanding of how cholesterol levels may contribute to the behavioral phenotype of SLOS. These findings may inform future studies related to the role cholesterol synthesis defects play in the behavioral phenotype of SLOS and, subsequently, modalities of intervention for behavioral symptoms.

KW - Phenotype

KW - Sleep

KW - Smith-Lemli-Opitz syndrome

UR - http://www.scopus.com/inward/record.url?scp=84974622166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974622166&partnerID=8YFLogxK

U2 - 10.1097/DBP.0000000000000317

DO - 10.1097/DBP.0000000000000317

M3 - Article

C2 - 27244299

AN - SCOPUS:84974622166

VL - 37

SP - 424

EP - 430

JO - Journal of Developmental and Behavioral Pediatrics

JF - Journal of Developmental and Behavioral Pediatrics

SN - 0196-206X

IS - 5

ER -